Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CTSK | P43235 | 8/20 | 0.42 |
| ▸ | CTSS | P25774 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | GLS | O94925 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8098563 | 1.00 | CA1 (0.50) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL7765532 | 0.86 | CA1 (0.46) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL20254237 | 0.84 | CA1 (0.47) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL20254210 | 0.84 | CA1 (0.47) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL23607312 | 0.81 | CA1 (0.52) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL1563568 | 0.81 | CA1 (0.52) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL148100 | 0.81 | CA1 (0.52) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL148099 | 0.81 | CA1 (0.52) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL23849248 | 0.81 | CA1 (0.52) | CA1CA2CA7CYP2D6KMT2A | |
| SCHEMBL1369240 | 0.81 | CA1 (0.52) | CA1CA2CA7CYP2D6KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112430243-B | Method for preparing thioester compound | 江西师范大学 | 2023-03-21 | — | — | CN | disclosed |
| CN-112430243-A | Method for preparing thioester compound | 江西师范大学 | 2021-03-02 | — | — | CN | disclosed |
| US-20110282081-A1 | Methods of Preparing 1-Deoxy-Sphingoid Bases and Derivatives Thereof | EMORY UNIVERSITY (US) | 2011-11-17 | — | — | US | disclosed |
| WO-2010085547-A2 | METHODS OF PREPARING 1-DEOXY-SPHINGOID BASES AND DERIVATIVES THEREOF | EMORY UNIVERSITY (US) | 2010-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282081-A1 | Methods of Preparing 1-Deoxy-Sphingoid Bases and Derivatives Thereof | DEGS1, SPHK1, SPHK2 | CA1 1708/4885CA2 3287/4885CA7 2209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.